Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre- and Post-operative Circulating Tumoral DNA in Patients With Medullary Thyroid Carcinoma.

The Journal of clinical endocrinology and metabolism - 14 Jul 2022

Ciampi Raffaele, Romei Cristina, Ramone Teresa, Matrone Antonio, Prete Alessandro, Gambale Carla, Materazzi Gabriele, De Napoli Luigi, Torregrossa Liborio, Basolo Fulvio, Castagna Maria Grazia, Brilli Lucia, Ferretti Elisabetta, Elisei Rossella

Abstract excerpt

CONTEXT: Measurement of driver mutations in circulating tumoral DNA (ctDNA) obtained by liquid biopsy has been shown to be a sensitive biomarker in several human tumors. OBJECTIVE: The aim of this study was to evaluate the clinical relevance of pre- and post-operative ctDNA in sporadic medullary thyroid cancer (sMTC). METHODS: We studied pre- and post-operative ctDNA in 26 and 23 sMTC patients, respectively....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoembryonic Antigen

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Neuroendocrine

Share to Circulating Tumor DNA

Share to Mutation

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 35470851
DOI: 10.1210/clinem/dgac222

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre- and Post-operative Circulating Tumoral DNA in Patients With Medullary Thyroid Carcinoma.PMID 35470851Read ↗

Liquid Biopsy-Based RET Mutation Profiling to Guide RET Inhibitor Treatment in Sporadic Medullary Thyroid Carcinoma May Be Useful in Cases with High Tumor Burden and Progressive Disease.Semantic proximity Read ↗

Precision management of medullary thyroid carcinoma: a dynamic framework integrating biomarkers, genotyping, and risk stratification.Semantic proximity Read ↗

Current status of the prognostic molecular markers in medullary thyroid carcinomaSemantic proximity Read ↗

A cohort study on 10-year survival of sporadic medullary thyroid carcinoma with somatic RET mutation.Semantic proximity Read ↗

Genetic Alterations in Medullary Thyroid Cancer: Diagnostic and Prognostic MarkersSemantic proximity Read ↗

Circulating Biomarkers in Medullary Thyroid Carcinoma: Assays, Clinical Performance, and Integrated AlgorithmsSemantic proximity Read ↗

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.Semantic proximity Read ↗

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.Semantic proximity Read ↗

Utility of serum thyroglobulin measurements after prophylactic thyroidectomy in patients with hereditary medullary thyroid cancer.Semantic proximity Read ↗

Familial thyroid neoplasia: impact of technological advances on detection and monitoring.Semantic proximity Read ↗

MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome.Semantic proximity Read ↗

Critically evaluated key points on hereditary medullary thyroid carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.